SEC Info - Ra Capital Management, L.P., et al. - ‘SC 13D’ on 7/16/21 re: Acumen Pharmaceuticals, Inc.

SEC Info℠

Home

Help

Please Sign In

Ra Capital Management, L.P., et al. – ‘SC 13D’ on 7/16/21 re: Acumen Pharmaceuticals, Inc. – ‘EX-99.1’

On: Friday, 7/16/21, at 4:30pm ET · Accession #: 1104659-21-93091 · File #: 5-92677

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/16/21  Ra Capital Management, L.P.       SC 13D                 2:106K Acumen Pharmaceuticals, Inc.      Toppan Merrill/FA
          Peter Kolchinsky
          Ra Capital Healthcare Fund, L.P.
          Rajeev Shah

Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      Statement of Acquisition of Beneficial Ownership    HTML     56K 
                by an "Active" Investor                                          
 2: EX-99.1     Miscellaneous Exhibit                               HTML      9K

‘EX-99.1’ — Miscellaneous Exhibit

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 1

JOINT FILING AGREEMENT

This Joint Filing Agreement, dated as of July 16, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).

Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to Common Stock, par value $0.0001 per share of Acumen Pharmaceuticals, Inc. beneficially owned by them from time to time.

Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D (and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

This Joint Filing Agreement may be terminated by any of the Filers upon one week’s prior written notice or such lesser period of notice as the Filers may mutually agree.

Executed and delivered as of the date first above written.

RA CAPITAL MANAGEMENT, L.P.

By:	/s/ *Peter Kolchinsky*
	Name:	Peter Kolchinsky
	Title:	Authorized Signatory

PETER KOLCHINSKY

/s/ *Peter Kolchinsky*

RAJEEV SHAH

/s/ *Rajeev Shah*

RA CAPITAL HEALTHCARE FUND, L.P.

By:	RA Capital Healthcare Fund GP, LLC
Its:	General Partner

By:	/s/ *Peter Kolchinsky*
	Name:	Peter Kolchinsky
	Title:	Manager

Dates Referenced Herein

This ‘SC 13D’ Filing	Date	Other Filings

Filed on:	7/16/21	None on these Dates
		List all Filings

↑Top

Filing Submission 0001104659-21-093091 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)